Conflans-Sainte-Honorine, France

Pierre Sugranes

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cellprothera. Active years: 2020.


% Patents Active = 100.0



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre Sugranes: Innovator in Automated Cell Culture Technology

Introduction

Pierre Sugranes is a notable inventor based in Conflans-Sainte-Honorine, France. He has made significant contributions to the field of biotechnology, particularly in the area of automated cell culture systems. His innovative approach aims to enhance the efficiency and effectiveness of cell culture processes.

Latest Patents

Pierre Sugranes holds a patent for an "Automated apparatus and method of cell culture." This invention provides an automated apparatus that includes tanks for culture medium, growth factors, and cells to be cultured. The system features an incubator with a thermostated enclosure that houses a cell culture vessel, along with a control computer system. Additionally, it incorporates a supporting and agitation device for the culture vessel, which is designed as a bag with multiple ports for connection to harvesting and storage devices.

Career Highlights

Pierre Sugranes is associated with Cellprothera, a company focused on advancing cell therapy technologies. His work at Cellprothera emphasizes the importance of automation in cell culture, which can lead to improved outcomes in research and therapeutic applications.

Collaborations

Pierre collaborates with talented individuals such as Philippe Henon and Claire Saucourt, who contribute to the innovative environment at Cellprothera. Their combined expertise fosters advancements in cell culture technologies.

Conclusion

Pierre Sugranes is a pioneering inventor whose work in automated cell culture technology is shaping the future of biotechnology. His contributions are vital for enhancing the efficiency of cell culture processes, ultimately benefiting research and therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…